New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
Cat.No. | Product Name | Activity |
5175 | AEBSF | Broad spectrum, irreversible inhibitor of serine proteases |
5110 | GSK 1562590 hydrochloride | High affinity and selective urotensin II (UT) receptor antagonist |
5051 | BIO 5192 | Highly potent and selective inhibitor of integrin α4β1 |
5021 | TC-G 1000 | Potent and selective α2D agonist |
5169 | Noradrenaline bitartrate | Endogenous adrenergic hormone and neurotransmitter |
5180 | Ferrostatin 1 | Selective inhibitor of erastin induced ferroptosis |
5151 | Prosaptide TX14(A) | Potent GPR37 and GPR37L1 agonist |
5113 | AbK | Photo-crosslinking probe |
5036 | ML 786 dihydrochloride | Potent Raf kinase inhibitor; orally bioavailable |
4886 | RU-SKI 43 hydrochloride | Hedgehog acyltransferase (Hhat) inhibitor; cell permeable |
4875 | Senexin A | Cyclin-dependent kinase 8 (cdk8) inhibitor |
2305 | Tautomycetin | Selective PP1 inhibitor |
5172 | FLI 06 | Inhibitor of Notch signaling |
5148 | Wnt-C59 | Highly potent Porcn inhibitor |
5128 | C 21 | Selective PRMT1 arginine methyltransferase inhibitor |
4964 | R 1485 dihydrochloride | Selective and high affinity 5-HT6 antagonist |
1286 | LY 231617 | Antioxidant; neuroprotective in vitro and in vivo |
5099 | TC-E 5003 | Selective PRMT1 arginine methyltransferase inhibitor |
5050 | CASIN | Cdc42 GTPase inhibitor |
4978 | Pyrintegrin | Enhances survival of human ESCs following enzymatic dissociation |
4934 | MA 2029 | Potent and selective, competitive motilin receptor antagonist; orally active |
4898 | TC-E 5006 | γ-secretase modulator; reduces Aβ42 levels |